Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. judge asks if owners of opioid maker Purdue abused bankruptcy to shield assets

Published 11/30/2021, 05:52 PM
Updated 11/30/2021, 05:58 PM
© Reuters. FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, U.S., April 25, 2017.   REUTERS/George Frey

By Maria Chutchian

(Reuters) - A U.S. judge on Tuesday questioned whether members of the Sackler family that owned Purdue Pharma abused the bankruptcy system, as she considers whether to overturn a ruling that shielded the Sacklers from liability over the opioid epidemic.

U.S. District Judge Colleen McMahon in Manhattan said she wanted more information about more than $10 billion that the Sacklers, according to court documents, received from Purdue between 2008 and 2018, when they left the company’s board.

“I’m looking for whether there was abuse,” she said during a hearing.

One Sackler family lawyer replied that there was no evidence to suggest abuse. The Sacklers have denied wrongdoing and did not themselves file for bankruptcy. They contributed $4.5 billion to the bankruptcy settlement in exchange for protection against future litigation.

McMahon's remarks came during arguments over appeals of a bankruptcy court’s approval in September of Purdue’s reorganization plan, which included releases of future opioid-related civil claims against the Sacklers.

The U.S. Department of Justice’s bankruptcy watchdog and a small group of states are challenging the plan's approval, claiming the Sacklers should not receive the legal protections it provides.

McMahon suggested that the Sacklers may have protected their wealth by taking as much money from Purdue as they could in the years before the bankruptcy.

“People were aware claims were going to be asserted. Advisors told them to take steps to protect the family,” she said.

A lawyer for the Mortimer Sackler side of the family, Maura Monaghan of Debevoise & Plimpton, told the judge there was “not a shred of evidence” that the Sacklers made any decisions with the intention that Purdue would ultimately wind up in bankruptcy. She noted that the Sacklers left the Purdue board in 2018, before the 2019 bankruptcy filing, and that the last distributions they received from the company occurred around 2016.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Monaghan said the judge’s concern about potential bankruptcy abuse “would be based on nothing but speculation.”

But the judge said she may send the matter back to the bankruptcy judge who approved the deal this fall.

Around 500,000 people have died from opioid overdoses since 1999, according to the Centers for Disease Control and Prevention. Purdue filed for bankruptcy in September 2019 in the face of 3,000 lawsuits accusing it and Sacklers of contributing to the opioid crisis.

Latest comments

Apply the clawback law just like they do to individuals that get money from someone and the the giver goes into a nursing home, the government always goes after the heirs cover the nursing home costs.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.